Retrospective Evaluation of LDL-C Levels Following First Treatment With Inclisiran as Part of Secondary Prevention ASCVD Risk Reduction in a Real-World Primary Care Setting

• Main Authors: Carl N. Deaney (Author), Meredith P. Donaldson (Author), Danielle M. Reesby (Author), Victoria L. Scott (Author), Victoria Ellis (Author), Georgia E. Cole (Author), Natalie M. C. Daly (Author), Sophie C. McKechnie (Author), Michelle Daff (Author), Sarah L. Knudsen (Author), Charles H. Hemingway-Deaney (Author), Alena Nicholson (Author), Laura Siauciuniene (Author), Azeem Azeez (Author), Agne Meskauskiene (Author)
• Format: Book
• Published: SAGE Publishing, 2024-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death and disability worldwide. There is a direct relationship between increasing levels of LDL-C and increased risk of ASCVD. Guidance from the European Society of Cardiology (ESC) and the European Atherosclerosis...